Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2005-01-25
2005-01-25
Barts, Samuel (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S347000, C564S342000, C514S649000, C514S651000
Reexamination Certificate
active
06846957
ABSTRACT:
The present invention concerns a method of synthesizing fluoxetine hydrochloride. The method includes the synthesis of 3-methylamino-1-phenyl-1-propanol by reduction of 1-phenyl-3-methylamino-2-propen-1-one with sodium borohydride and acetic acid.
REFERENCES:
patent: 4194009 (1980-03-01), Molloy et al.
patent: 4296126 (1981-10-01), Nedelec et al.
patent: 4314081 (1982-02-01), Molloy et al.
patent: 4902710 (1990-02-01), Foster et al.
patent: 5104899 (1992-04-01), Young et al.
patent: 5166437 (1992-11-01), Kairisalo et al.
patent: 5225585 (1993-07-01), Schwartz et al.
patent: 5310756 (1994-05-01), Jakobsen et al.
patent: 5356934 (1994-10-01), Robertson et al.
patent: 5708035 (1998-01-01), Young et al.
patent: 5760243 (1998-06-01), Theriot
patent: 5936124 (1999-08-01), Hilborn et al.
patent: 6025517 (2000-02-01), Hilborn et al.
patent: 0380924 (1990-08-01), None
patent: 0457559 (1991-11-01), None
patent: 0529842 (1993-03-01), None
patent: 2101650 (1997-07-01), None
patent: 2103681 (1997-09-01), None
patent: 81083 (1990-05-01), None
patent: 2060618 (1981-05-01), None
patent: 207035 (1993-03-01), None
patent: WO 9309769 (1993-05-01), None
patent: WO 9400416 (1994-01-01), None
patent: WO 9811054 (1998-03-01), None
patent: WO 9905129 (1999-02-01), None
patent: WO 9906362 (1999-02-01), None
patent: WO 9967196 (1999-12-01), None
patent: WO 0007976 (2000-02-01), None
patent: WO 0021917 (2000-04-01), None
patent: WO 0037425 (2000-06-01), None
patent: WO 0144166 (2001-06-01), None
CAS Online Printout 1955:16022;, Hirao, RN=877-50-9.*
Ager and Laneman, “Reductions of 1,3-dicarbonyl systems with ruthenium-biary1bisphosphine catalysts,”Tet. Asymmetry, 8(20)3327-3355, Report No. 30, 1997.
Arce, “Process for the preparation of fluoxetine and its addition salts,”Chem. Abstr., 129:260223, 1998.
Bartoli et al., “Convenient procedure for the reduction of β-enamino ketones: synthesis of γ-amino alcohols and tetrahydro-1,3-oxazines,”J. Chem. Soc., 1:537-543, 1994.
Chatterjee and Rudorf, “Reaction of enaminones with thiacumulenes,” In:Phosphorus, Sulfur and Silicon and the Related Elements, 133:251-266, 1998.
Chenevert and Fortier, “Chemoenzymatic synthesis of both enantiomers of fluoxetine,”Chem. Lett., 9:1603-1606, 1991.
Corey and Reichard, “Enantioselective and practical synthesis of R- and S-fluoxetines,”Tetrahedron Lett., 30(39):52075210, 1989.
Gao and Sharpless, “Asymmetric synthesis of both enantiomers of tomoxetine and fluoxetine. Selective reduction of 2,3-epoxycinnamyl alcohol with red-A1,”J. Org. Chem., 53:4081-4084, 1988.
Hilborn et al., “Fluoxetine chiral process from benzoylpropionic acid,”Chem. Abstr., 131:170168, 1999.
Kairisalo et al.., “New method for preparation of fluoxetine hydro-chloride,”Chem. Abstr., 114:42266,1991.
Kumar and Dike, “A novel chemoenzymatic enantioselective synthesis of some clinically effective CNS drugs and related compounds,”Indian J. Chem., 31B:803-809, 1992.
Kumar et al., “A new chemoenzymatic enantioselective synthesis of R-(-)-tomoxetine, (R)- and (S)-fluoxetine,”Tetrahedron Lett., 32:1901-1904, 1991.
Mitchell and Koenig,“Synthesis of R- and S-fluoxetine norfluoxetine and related compounds from styrene oxide,”Synth. Commun., 25:1231-1238, 1995.
Pedregal, “Preparation of fluoxetine via the Michael addition,”Chem. Abstr., 128:114779, 1998.
Robertson et al. “Synthesis of 14C- and 3H-labeled fluoxetine, a selective serotonin uptake inhibitor,”J. Labeled Compound Radiopharm., 24:1397-1404, 1987.
Robertson et al., “Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor,”J. Med. Chem., 31:1412-1417, 1988.
Sakuraba and Achiwa, “Efficient asymmetric hydrogenation of β- and γ-amino ketone derivatives leading to practical synthesis of fluoxetine and eprozinol,”Chem. Pharm. Bull., 43:748-753, 1995.
Sakuraba and Achiwa,“Practical asymmetric synthesis of (R)-fluoxetine hydrochloride catalyzed by (2S,4S)-4-dicyclohexylphosphino-2-diphenylphosphinomethyl-1-(N-methylcarbamoyl)pyrrolidine-rhodium comples,” Syn. Lett., 689-690, 1991.
Schwartz et al., “Preparation of fluoxetine,”Chem. Abstr., 119:8485, 1993.
Theriot, “Preparation and use of 2-methyl-5-phenylisoxazolidine,”Chem. Abstr., 129:54356, 1998.
Theriot, “Preparation of hydrocarbyInitrones as isoxazolidine precursors,”Chem. Abstr.130:153652, 1999.
Weber and Marti, “Amination and etherification method for producing fluoxetine,”Chem. Abstr., 133: 58607, 2000.
Wirth et al., “Identification and comparison of impurities in fluoxetine hydrochloride synthesized by seven different routes,”Organic Proc. Res. Dev., 4:513-519, 2000.
Young and Barberich, “Methods and compositions for treating depression using optically pure fluoxetine,”Chem. Abstr., 117:7635, 1992.
Young and Barberich, “Preparation of and pharmaceutical formulations utilizing pure (S+) enantomer fluoxetine,”Chem. Abstr., 119:203106, 1993.
Barts Samuel
Board of Regents , The University of Texas System
Fulbright & Jaworski L.L.P.
LandOfFree
Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3405949